- Published at
- by financialpost.com
mixed
mixed
ImmunoPrecise Antibodies Announces Key Leadership Changes
AUSTIN, Texas — ImmunoPrecise Antibodies (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, is pleased to announc…